早期宫颈癌盆腔前哨淋巴结流程中应常规切除宫旁上段淋巴血管组织
结论认为切除UPLT应成为早期宫颈癌前哨淋巴结流程的组成部分。
要点
- 52.4%患者检出UPLT淋巴结,6例有UPLT转移,其中3例无侧盆腔淋巴结转移。
- 切除UPLT未发生术中并发症,支持将其纳入前哨淋巴结流程。
核心结论
- 切除宫旁上段淋巴血管组织应成为早期宫颈癌前哨淋巴结流程的组成部分。
主要发现
- 76例(52.4%)检出至少一枚UPLT淋巴结,6例有UPLT淋巴结转移。
- 6例UPLT转移中3例(占全部2.1%、占淋巴结阳性15.8%)无侧盆腔淋巴结转移。
- 13例有侧盆腔前哨淋巴结转移者中,5例UPLT无转移、8例UPLT为良性。
- 切除UPLT未发生术中并发症。
临床怎么用
- 早期宫颈癌行前哨淋巴结活检时,应同时单独切除宫旁上段淋巴血管组织送超分期和免疫组化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate the prevalence of lymph nodes and lymph node metastases (LNMs) in the upper paracervical lymphovascular tissue (UPLT) in early stage cervical cancer. METHODS: In this prospective study consecutive women with stage IA1-IB1 cervical cancer underwent a pelvic lymphadenectomy including identification of sentinel nodes (SLNs) as part of a nodal staging procedure in conjunction with a robotic radical hysterectomy (RRH) or robotic radical trachelectomy (RRT). Indocyanine green (ICG) was used as tracer. The UPLT was separately removed and defined as "SLN-parametrium" and, as all SLN tissue, subjected to ultrastaging and immunohistochemistry. Primary endpoint was prevalence of lymph nodes and metastatic lymph nodes in the UPLT. Secondary endpoints were complications associated with removal of the UPLT. RESULTS: One hundred and forty-five women were analysed. Nineteen (13.1%) had pelvic LNMs, all identified by at least one metastatic SLN. In 76 women (52.4%) at least one UPLT lymph node was identified. Metastatic UPLT lymph nodes were identified in six women of which in three women (2.1% of all women and 15.8% of node positive women) without lateral pelvic LNMs. Thirteen women had lateral pelvic SLN LNMs with either no (n = 5) or benign (n = 8) UPLT lymph nodes. No intraoperative complications occurred due to the removal of the UPLT. CONCLUSION: Removal of the UPLT should be an integral part of the SLN concept in early stage cervical cancer.
引用
- Lührs O, Ekdahl L, Geppert B, et al. Resection of the upper paracervical lymphovascular tissue should be an integral part of a pelvic sentinel lymph node algorithm in early stage cervical cancer. Gynecol Oncol. 2021. PMID: 34509298. doi:10.1016/j.ygyno.2021.08.031
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。